免疫系统
毒力
医学
抗生素
病菌
炎症
肺炎克雷伯菌
抗菌剂
抗感染药
草药提取物
免疫学
致病菌
寄主(生物学)
生物
微生物学
消炎药
药理学
植物化学
氧化应激
促炎细胞因子
药用植物
作者
Uzma Saqib,Sakina Ratlamwala,Nidhi Kibe,Mirza Rafi Baig,Krishnan Hajela,Sadhana Sharma
标识
DOI:10.3389/fimmu.2026.1767981
摘要
Klebsiella pneumoniae (Kp) is a multidrug-resistant (MDR) pathogen responsible for severe infections such as pneumonia, sepsis, and urinary tract infections. Its pathogenicity includes both bacterial virulence factors and host-driven inflammatory responses thereby complicating treatment outcomes. Herbal compounds (phytochemicals) have recently gained attention as promising dual-action therapeutic agents that target both infection and inflammation. Phytochemicals such as curcumin, berberine, quercetin, resveratrol, and several medicinal plant extracts have demonstrated an integrated ability to mitigate both infection as well as host inflammation in preclinical studies. Their ability to attenuate virulence, reduce oxidative stress, and regulate host immune signaling positions them as potential candidates for adjunctive therapy against Kp infections. Furthermore, phytochemical-antibiotic combinations demonstrate synergistic effects, enhancing bacterial clearance and reducing antibiotic dosage requirements. Overall, the dual action of phytochemicals makes them as valuable candidates for integrative therapies against Kp infections and related inflammatory diseases. Unlike the prior reviews, the present review uniquely focusses the dual antibacterial and immunomodulatory actions of plant-derived compounds against Kp. It adds a novel perspective integrating the therapeutic promise of phytochemicals with a systematic analysis of their translational limitations. Further, it provides a rational framework to guide future development of phytochemicals as potent and clinically viable therapeutics against Kp infections.
科研通智能强力驱动
Strongly Powered by AbleSci AI